🔗 Permalink

Inventor profile of:

Michael Adler

City:

Riehen

Country:

Switzerland

Published Applications:

Last publication date:

2021-11-18

Top Assignees for applications by Michael Adler

The entities that hold a legal rights for patent applications filed by inventor Adler Michael:

Genentech, Inc. 10 South San Francisco, CA United States
Hoffmann-La Roche Inc. 1 Nutley, NJ United States
Hoffmann-La Roche.Inc. 1 Nutley, NJ United States

Recent patent applications by Adler Michael

Michael Adler from Riehen, CH has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2021-11-18

US20210353753A1

Human necessities

Subcutaneous anti-HER2 Antibody Formulations and Uses Thereof

#2 | 2021-02-25

US20210054092A1

Chemistry; metallurgy

HIGHLY CONCENTRATED PHARMACEUTICAL FORMULATIONS

#3 | 2019-12-05

US20190367629A1

Chemistry; metallurgy

Highly concentrated pharmaceutical formulations

#4 | 2018-08-16

US20180228895A1

Human necessities

Subcutaneous anti-HER2 Antibody Formulations and Uses Thereof

#5 | 2016-06-16

US20160166689A1

Human necessities

Subcutaneous anti-HER2 antibody formulations and uses thereof

#6 | 2016-05-19

US20160137742A1

Chemistry; metallurgy

Highly concentrated pharmaceutical formulations

#7 | 2015-03-26

US20150086537A1

Chemistry; metallurgy

Highly concentrated pharmaceutical formulations

#8 | 2013-09-26

US20130251725A1

Human necessities

Anti-P-Selectin Antibody Formulation

#9 | 2013-08-22

US20130216532A1

Human necessities

Subcutaneous anti-HER2 Antibody Formulations and Uses Thereof

#10 | 2012-05-24

US20120128687A1

Chemistry; metallurgy

NOVEL ANTIBODY FORMULATION

#11 | 2011-06-30

US20110158987A1

Human necessities

NOVEL ANTIBODY FORMULATION

#12 | 2011-03-31

US20110076273A1

Chemistry; metallurgy

Highly Concentrated Pharmaceutical Formulations

#13 | 2011-02-24

US20110044977A1

Human necessities

Subcutaneous anti-HER2 antibody formulations and uses thereof

InventorID:

400979 ⎘